Cite
Dillman A, Zoratti MJ, Park JJH, et al. The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infect Drug Resist. 2020;13:4577-4587doi: 10.2147/IDR.S288399.
Dillman, A., Zoratti, M. J., Park, J. J. H., Hsu, G., Dron, L., Smith, G., Harari, O., Rayner, C. R., Zannat, N. E., Gupta, A., Mackay, E., Arora, P., Lee, Z., & Mills, E. J. (2020). The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infection and drug resistance, 134577-4587. https://doi.org/10.2147/IDR.S288399
Dillman, Alison, et al. "The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries." Infection and drug resistance vol. 13 (2020): 4577-4587. doi: https://doi.org/10.2147/IDR.S288399
Dillman A, Zoratti MJ, Park JJH, Hsu G, Dron L, Smith G, Harari O, Rayner CR, Zannat NE, Gupta A, Mackay E, Arora P, Lee Z, Mills EJ. The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infect Drug Resist. 2020 Dec 22;13:4577-4587. doi: 10.2147/IDR.S288399. eCollection 2020. PMID: 33376364; PMCID: PMC7764888.
Copy
Download .nbib